J Nephropathol. 2012;1(2): 81-82. doi: 10.5812/nephropathol.7475
PMID: 24475393        PMCID: PMC3886140

Commentary

Erythropoietin; bright future and new hopes for an old drug


Cited by CrossRef: 7


1- Nasri H. The protective effect of recombinant human erythropoietin against cisplatin-induced renal and hepatic dysfunctions in Wistar rats. Hum Exp Toxicol. 2014;33(10):1085 [Crossref]
2- Rafieian-Kopaei M, Nasri H. Comment on: Preventive effect of Teucrium polium on learning and memory deficits in diabetic rats. Med Sci Monit Basic Res. 2013;19:208 [Crossref]
3- Baradaran A, Nasri H, Rafieian-Kopaei M. Erythropoietin and renal protection. DARU. 2013;21(1):78 [Crossref]
4- Nematbakhsh M, Nasri H. Cisplatin nephrotoxicity may be sex related. Kidney International. 2013;83(6):1201 [Crossref]
5- Rafieian-Kopaei M, Nasri H. Comment on: Is the renoprotective effect of erythropoietin in chronic kidney disease a myth?. Journal of the Formosan Medical Association. 2014;113(1):62 [Crossref]
6- Rafieian-Kopaei M, Nasri H. Comment on “Carbamylated Erythropoietin Ameliorates Cyclosporine Nephropathy without Stimulating Erythropoiesis”. Cell Transplant. 2014;23(12):1673 [Crossref]
7- Rafieian-Kopaie M, Nasri H. R: Recombinant human erythropoietin reduces rhabdomyolysis-induced acute renal failure in rats. Injury. 2013;44(11):1662 [Crossref]